Protein Supplementation and Mixed Power Training on Muscle Function and Functional Capacities in Elderly Men
NCT ID: NCT03393650
Last Updated: 2018-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2013-09-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Strength Training and Protein Supplementation in Old Pre-frail Individuals
NCT03723902
Effect of Protein Consumption and Resistance Training on Body Composition, Muscular Strength and Functional Capacity in the Elderly
NCT03862937
A Protein Supplementation and Exercise Strategy to Promote Muscle Protein Anabolism in Frail Elderly People
NCT01110369
The Effects of Resistance Training and Protein Supplementation in Healthy Elderly Men and Women.
NCT01004588
Resistance Training in Elderly
NCT00744094
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Recently, it has been observed than muscle quality is more important to maintain physical autonomy than muscle mass per se. In addition, muscle quality is more related to functional capacities than muscle mass.
Due to this recent finding, it has been proposed that muscle power training would be the best exercise intervention to prevent the loss of mobility.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise + Placebo group
50 subjects will receive a placebo supplementation with an exercise intervention (EX group)
Exercise + Placebo group
1/2 of the subject will follow a mixed power training: 4 power exercises + 6 functional exercises combined to a placebo
Exercise + Protein group
50 subjects will receive a protein supplementation combined with an exercise intervention (PROTEX group)
Exercise + Protein group
1/2 of the subject will receive 30 g/ d of protein (leucine+ vitD; divided in three equal doses: morning, afternoon and evening) + will follow a mixed power training: 4 power exercises + 6 functional exercises.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise + Placebo group
1/2 of the subject will follow a mixed power training: 4 power exercises + 6 functional exercises combined to a placebo
Exercise + Protein group
1/2 of the subject will receive 30 g/ d of protein (leucine+ vitD; divided in three equal doses: morning, afternoon and evening) + will follow a mixed power training: 4 power exercises + 6 functional exercises.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 60 years and older
* Sedentary men
* Not obese (BMI \<30 kg/m2)
* Living in free-living community
Exclusion Criteria
* Having Lactose intolerance
* Having Pace marker
* Having Metabolism disorder
* No weight stable since the last 6 months
* No stable medication (same dose and type since at least 6 months)
60 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université du Québec a Montréal
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mylène Aubertin-Leheudre
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
mylene aubertin-leheudre, PhD
Role: PRINCIPAL_INVESTIGATOR
Université du Québec a Montréal
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UQAM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.